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Renal replacement therapy (RRT) is associated with 
potential risks such as hypotension, catheter-related 
complications, hemorrhage and blood–extracorporeal 
circuit interactions. Several studies, however, have shown 
that early RRT in acute kidney injury (AKI) is associated 
with a better outcome in intensive care unit (ICU) 
patients [1-3].
A recent retrospective study published in Critical Care
has questioned the use of RRT in critically ill patients, 
including those with severe AKI [4]. Compared with 
conservative treatment, RRT patients showed a higher 
mortality. Th   e indication for RRT was at the discretion of 
the physician, and patients receiving RRT presented 
higher severity and renal impairment scores. After multi-
variate analysis correcting for severity of illness (Acute 
Physiology and Acute Chronic Health Evaluation II score 
and Sequential Organ Failure Assessment score), mor  tality 
remained higher in RRT patients. In a multivariate 
analysis in septic shock patients, however, we observed 
that both severity scores are not related to mortality, 
contrary to the maximum Sequential Organ Failure 
Assessment score [5]. Th  e decision of starting RRT in 
many patients during their ICU stay may have been 
related to evolving factors not included in the analysis 
(worsening severity, overload, progressing hypoxemia, 
and so forth), which aﬀ  ect mortality but are not detected 
in the initial snapshot assessment. For instance, it is 
inconceivable that anuric patients did not receive RRT. 
On the other hand, the use of RRT in some patients with 
mild renal impairment may have increased morbidity.
Th   e study underlines the idea that RRT is not necessary 
in many patients presenting mild AKI in the ICU, but 
may be misleading if we accept that this therapy is 
deleterious in general.
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We appreciate the comments of Dr Pestaña and under-
stand his concerns about a possible misinterpretation of 
the results by considering our ﬁ  ndings in too general a 
manner.
First, however, we have to rectify that the overall 
Stuiven  berg Hospital Acute Renal Failure results pub-
lished in this journal did not derive from retrospective 
observations but from a prospective study of 1,303 AKI 
patients consecutively admitted to the ICU. Furthermore, 
disease severity was initially investigated using the 
Stuivenberg Hospital Acute Renal Failure score [6]. Th  is 
validated AKI-speciﬁ  c severity scoring system proved to 
have high perfor  mance in comparison with other general 
and speciﬁ  c severity scores [7]. It was only additionally 
that we corrected for Acute Physiology and Acute Chronic 
Health Evaluation II and Sequential Organ Failure Assess-
ment scores, both showing only a limited predictive value 
for mortality.
We agree with Pestaña that in some of the critically ill 
AKI patients, the indication to start RRT treatment is 
clearly established. Recent reviews, however, demon-
strated that the available literature remains inconclusive 
regarding the optimal indications for RRT in AKI patients 
[8,9]. Arguably only metabolic acidosis, hypervolemia 
and hyper  kalemia that do not respond to other forms of 
therapy are absolute indications for initiation of RRT [8].
In the Stuivenberg Hospital Acute Renal Failure study, 
we determined RRT as an independent risk factor for 
mortality. In view of the current lack of evidence for 
initiating RRT, we tried to formulate our recom  men-
dations carefully – stating only that a more critical 
approach to the need for RRT in AKI patients seems to 
be warranted, and pleading for an individualized 
approach in each patient.
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